Timothy P. Clackson - Insider Trading & Ownership

Entity
Individual
Location
C/O Ariad Pharmaceuticals Inc, 26 Landsdowne Street, Cambridge, MA
Summary
The estimated net worth of Timothy P. Clackson is at least $239K dollars as of June 17, 2024. Timothy P. Clackson is the President and CEO, Director of Theseus Pharmaceuticals, Inc. and owns shares of Theseus Pharmaceuticals, Inc. stock worth about $139K. Timothy P. Clackson is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $75.5K. Timothy P. Clackson is the Director of Elevation Oncology, Inc. and owns shares of Elevation Oncology, Inc. (ELEV) stock worth about $24.1K.
All Insider Reports
All Insider Reports

Ownership of Timothy P. Clackson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
THRX Theseus Pharmaceuticals, Inc. President and CEO, Director $139K Mar 1, 2023
XLO Xilio Therapeutics, Inc. 10%+ Owner $75.5K Oct 21, 2021
ELEV Elevation Oncology, Inc. Director $24.1K Jun 13, 2024
FMTX Forma Therapeutics Holdings, Inc. Director Oct 14, 2022

Insider Transactions Reported by Timothy P. Clackson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.